))
Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast
Manage episode 381659226 series 3456244
Innhold levert av i3 Health and I3 Health. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av i3 Health and I3 Health eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting. In this interview, Dr. Park outlines the most significant updates presented at ASTRO and how he plans to incorporate them into the treatment of patients with SCLC. At the end of the interview, stay tuned to hear Dr. Park's full presentation and claim credit at https://gate.sc/?url=https%3A%2F%2Fwww.i3health.com%2Fcourse-information%2Fvideo-viewpoint-strategy-session-optimizing-treatment-selection-sequencing-and-tolerability-in-small-cell-lung-cancer&token=7e964b-1-1698857353561
…
continue reading
38 episoder
Del
